Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125180312 | 12518031 | 2 | F | 20160625 | 20160802 | 20160630 | 20160809 | EXP | JP-PFIZER INC-2016319359 | PFIZER | 75.00 | YR | F | Y | 0.00000 | 20160809 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125180312 | 12518031 | 1 | PS | RHEUMATREX | METHOTREXATE SODIUM | 1 | Oral | 2 MG, 2X/DAY | 8 | MG | Y | 11719 | 2 | MG | CAPSULE | BID | |||
| 125180312 | 12518031 | 2 | SS | RHEUMATREX | METHOTREXATE SODIUM | 1 | Oral | 2 MG, 1X/DAY | 8 | MG | Y | 11719 | 2 | MG | CAPSULE | QD | |||
| 125180312 | 12518031 | 3 | C | CARDENALIN | DOXAZOSIN MESYLATE | 1 | Oral | 1 MG, 1X/DAY | 0 | 1 | MG | TABLET | QD | ||||||
| 125180312 | 12518031 | 4 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, 1X/DAY | 0 | 5 | MG | TABLET | QD | ||||||
| 125180312 | 12518031 | 5 | C | MAINTATE | BISOPROLOL FUMARATE | 1 | Oral | 5 MG, 1X/DAY | 0 | 5 | MG | TABLET | QD | ||||||
| 125180312 | 12518031 | 6 | C | TAKEPRON | LANSOPRAZOLE | 1 | Oral | 15 MG, 1X/DAY | 0 | 15 | MG | ORODISPERSIBLE TABLET | QD | ||||||
| 125180312 | 12518031 | 7 | C | RIMATIL | BUCILLAMINE | 1 | Oral | 100 MG, 2X/DAY | 0 | 100 | MG | TABLET | BID | ||||||
| 125180312 | 12518031 | 8 | C | RIMATIL | BUCILLAMINE | 1 | 0 | TABLET | |||||||||||
| 125180312 | 12518031 | 9 | C | RIMATIL | BUCILLAMINE | 1 | 0 | TABLET | |||||||||||
| 125180312 | 12518031 | 10 | C | ERYTHROCIN /00020901/ | ERYTHROMYCIN ETHYLSUCCINATE | 1 | Oral | 200 MG, 2X/DAY | 0 | 200 | MG | TABLET | BID | ||||||
| 125180312 | 12518031 | 11 | C | MUCODAIN | 2 | Oral | 500 MG, 3X/DAY | 0 | 500 | MG | TABLET | TID | |||||||
| 125180312 | 12518031 | 12 | C | MEDICON /00048102/ | DEXTROMETHORPHAN HYDROBROMIDE | 1 | Oral | 15 MG, 3X/DAY | 0 | 15 | MG | TABLET | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125180312 | 12518031 | 1 | Rheumatoid factor increased |
| 125180312 | 12518031 | 7 | Pain in extremity |
| 125180312 | 12518031 | 8 | Abulia |
| 125180312 | 12518031 | 9 | Malaise |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125180312 | 12518031 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125180312 | 12518031 | Altered state of consciousness | |
| 125180312 | 12518031 | Asthenia | |
| 125180312 | 12518031 | Ataxia | |
| 125180312 | 12518031 | Dysarthria | |
| 125180312 | 12518031 | Feeling abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125180312 | 12518031 | 1 | 20160623 | 20160623 | 0 | |
| 125180312 | 12518031 | 2 | 20160624 | 20160624 | 0 |